Rhumbline Advisers Vir Biotechnology, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 235,393 shares of VIR stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235,393
Previous 238,504 1.3%
Holding current value
$1.74 Million
Previous $2.12 Million 16.92%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$7.26 - $10.7 $22,585 - $33,287
-3,111 Reduced 1.3%
235,393 $1.76 Million
Q2 2024

Aug 01, 2024
BUY
$7.63 - $12.66 $74,903 - $124,283
9,817 Added 4.29%
238,504 $2.12 Million
Q1 2024

May 09, 2024
SELL
$8.6 - $11.9 $402,230 - $556,574
-46,771 Reduced 16.98%
228,687 $2.32 Million
Q4 2023

Feb 08, 2024
BUY
$7.76 - $10.29 $104,534 - $138,616
13,471 Added 5.14%
275,458 $2.77 Million
Q3 2023

Nov 09, 2023
BUY
$9.14 - $24.62 $131,378 - $353,887
14,374 Added 5.81%
261,987 $2.45 Million
Q2 2023

Aug 08, 2023
BUY
$23.2 - $27.29 $283,620 - $333,620
12,225 Added 5.19%
247,613 $6.07 Million
Q1 2023

May 11, 2023
BUY
$22.26 - $30.85 $326,465 - $452,446
14,666 Added 6.64%
235,388 $5.48 Million
Q4 2022

Feb 14, 2023
SELL
$19.96 - $28.22 $32,834 - $46,421
-1,645 Reduced 0.74%
220,722 $5.59 Million
Q3 2022

Nov 10, 2022
BUY
$18.26 - $31.1 $138,063 - $235,147
7,561 Added 3.52%
222,367 $4.29 Million
Q2 2022

Aug 11, 2022
BUY
$19.08 - $26.7 $2.86 Million - $4.01 Million
150,037 Added 231.65%
214,806 $5.47 Million
Q1 2022

May 12, 2022
BUY
$21.19 - $40.01 $19,388 - $36,609
915 Added 1.43%
64,769 $1.67 Million
Q4 2021

Feb 10, 2022
SELL
$30.97 - $54.03 $14,865 - $25,934
-480 Reduced 0.75%
63,854 $2.67 Million
Q3 2021

Nov 12, 2021
BUY
$34.9 - $54.54 $48,266 - $75,428
1,383 Added 2.2%
64,334 $2.8 Million
Q2 2021

Aug 05, 2021
BUY
$38.75 - $51.0 $99,432 - $130,866
2,566 Added 4.25%
62,951 $2.98 Million
Q1 2021

May 06, 2021
SELL
$26.34 - $83.07 $133,017 - $419,503
-5,050 Reduced 7.72%
60,385 $3.1 Million
Q4 2020

Feb 10, 2021
BUY
$25.51 - $43.38 $109,871 - $186,837
4,307 Added 7.05%
65,435 $1.75 Million
Q3 2020

Nov 12, 2020
SELL
$28.28 - $53.6 $217,162 - $411,594
-7,679 Reduced 11.16%
61,128 $2.1 Million
Q2 2020

Aug 13, 2020
BUY
$27.89 - $47.86 $1.62 Million - $2.79 Million
58,253 Added 551.95%
68,807 $2.82 Million
Q1 2020

May 06, 2020
BUY
$12.04 - $60.2 $127,070 - $635,350
10,554 New
10,554 $362,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email